NASDAQ:ETRM
Delisted

EnteroMedics Inc. Fund Signals

$2.05
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 37 days ( 0 % )
Last Price $2.05 0 %
High/ Low $2.05 - $2.05 0%
Chg 7 Days N/A $2.05 $2.05
Chg 30 Days N/A $2.05 $2.05
Chg 12 mos -85.04 % $13.70 $2.05
Trend - 3 mos 0.240 % Width: 3.43 %
Trend - 12 mos -71.26 % Width: 572.24 %
Pred. range - 3 mos $1.99 - $2.06 -2.96 % - 0.376 %
Pred. range - 12 mos N/A - $0.716 -100.00 % - -65.09 %
Short MA avg 3 mos Buy Oct 24, 2017 - 46 days
Long MA avg 3 mos Buy Dec 19, 2017 - 18 days
Short/Long MA avg 3 mos Buy Dec 19, 2017 - 18 days
Short MA avg 12 mos Sell Nov 20, 2017 - 38 days
Long MA avg 12 mos Buy Jan 12, 2018 - 3 days
Short/Long MA avg 12 mos Buy Jan 12, 2018 - 3 days
Pivot Short Buy Jan 15, 2018 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About EnteroMedics Inc.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sens... ETRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT